iBio Reports GAAP EPS of -$0.32, Revenue Misses Estimates
iBio (NASDAQ: IBIO) reported FY GAAP earnings per share (EPS) of -$0.32, which was in line with market expectations. However, the company's revenue came in at $1 million for the period, missing estimates by $400,000 and declining 75% year-over-year. The significant drop in revenue highlights ongoing challenges faced by iBio as it continues to operate under financial pressure. The results reflect a difficult operating environment or potential issues with sales execution during the reporting period. Despite meeting EPS expectations, the revenue shortfall may raise concerns among investors about future performance and operational stability.
Tickers: $IBIO
Topics: Earnings Revenue Miss